Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

GRACE and CCO Partnership - Information for a Diagnosis of Advanced NSCLC
Immunotherapy for Advanced NSCLC - Discussing Goals and Treatments with Your Health Care Provider
Author
Howard (Jack) West, MD
Image

In partnership with Clinical Care Options, GRACE Founder and President H. Jack West, MD provides this informational video regarding immunotherapy for advanced NSCLC and discussing goals and treatments with your health care providers.   We invite you to watch and join the conversation.  

For those dealing with questions regarding immune checkpoint inhibitor therapy, we have developed another helpful downloadable pdf for patients, Understanding the Current Landscape of Immune Checkpoint Inhibitor Therapy in Advanced NSCLC: A Resource for Patients.

Also in partnership with Clinical Care Options,  we have developed a helpful interactive online tool to help you understand more about your disease and treatment options.

Did you recently receive a diagnosis of non small cell lung cancer?

GRACE has partnered with Clinical Care Options to develop an interactive online tool to help you understand more about your disease and treatment options.  The goal of this tool is to help you better understand your diagnosis of locally advanced or metastatic NSCLC, to better understand your treatment options, and to become partners with the oncology team instead of being a bystander in your cancer care.  A series of questions developed by the experts allow you to select information about yourself and your cancer that are necessary to consider when making treatment choices in advanced NSCLC.  

Answer a series of multiple-choice questions and then get treatment options chosen by the 5 lung cancer experts listed below.

To assist you in gathering information click here to download a PDF consultation checklist with useful questions for your oncologist about your advanced NSCLC disease.  For additional tips please see "How to Talk to Your Oncologist".  If you are a health care provider, you can find CCO's clinician-focused tool here: https://www.clinicaloptions.com/oncology/programs/nsclc-clinical-insights/interactive-decision-support-tool/nsclc_tool_2018/page-1?origin=2.

 

Please  join the conversation!  We would love to hear from you! 

 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on